D'Amore, F. A., Relander, T., Lauritzsen, GF., Jantunen, E., Hagberg, H., Anderson, H., Holte, H., Ôsterborg, A., Merup, M., Brown, P. D. N., Kuittinen, O., Erlanson, M., Østenstad, B., Fagerli, U.-M., Gadeberg, OV., Sundström, C., Delabie, J., Ralfkiær, E. M., Vornanen, M. & Toldbod, H. (2012).
Upfront Autologuos Stem Cell Transplantation in Peripheral T-cell Lymphoma (NLG-T-01).
Journal of Clinical Oncology,
30(25), 3093-3099.
Vase, M. Ø., Friis, S., Andrea
, Sørensen, H. T. & D'Amore, F. A. (2011).
Absence of anaplastic large cell lymphoma (ALCL) cases in a very large cohort of Danish women exposed to breast implants: results of a nationwide, population-based study. Blood,
118, 3689.
Pedersen, M. B., Zhao, Y., Arendrup, MC.
, Bendix, K., Bojsen-Møller, M., Mølle, I. & D'Amore, F. A. (2011).
Co-existence of cerebral infection with Rhinocladiella mackenzei and primary central nervous system lymphoma in a HIV-negative patient.
Acta Pathologica et Microbiologica Scandinavica APMIS,
119(3), 221-223.
Vase, M. Ø., Hellberg, YK., Larsen, CS., Schaumburg, H.
, Bendix, K., Ravel, C., Bastien, P.
, Nyvold, C. G., Christensen, M. & D'Amore, F. A. (2011).
Development of splenic marginal zone lymphoma associated with active chronic visceral leishmaniasis. Blood,
118, 5202.
D'Amore, F. A., Gomes da Silva, M., Leppa, S., Relander, T., Pezzutto, A., Lauritzsen, GF., Weidmann, E., Van Gelder, M., Merup, M., Hagberg, H., Fagerli, UM., Brown, P. D. N., Boye Hansen, P., Mariz, JM., Jankovska, M., Walewski, J., Doorduijn, J., van Hoof, A.
, Christiansen, I. ... Toldbod, H. (2011).
First interim safety analysis of a phase III randomized trial in a newly diagnosed systemic peripheral T-cell lymphoma trated with CHOP chemotherapy with or without alemtuzumab and consolidated by autologous hematopoietic stem cell transplant. Blood,
118, 4110.
Kelsen, J., Schwindt, H., Dige, A. K., D'Amore, F. A., Pedersen, F. S., Agnholt, J., Christensen, L. A., Dahlerup, J. F. & Hvas, C. L. (2011).
Infliximab Induces Clonal Expansion of γδ-T Cells in Crohn’s Disease: A Predictor of Lymphoma Risk? P L o S One,
6(3), e17890.
https://doi.org/10.1371/journal.pone.0017890
Jantunen, E., Relander, T., Lauritzsen, G., Hagberg, H., Anderson, H., Cavallin-Ståhl, E., Holte, H., Østerborg, A., Merup, M., Brown, P., Kuittinen, O., Erlanson, M., Fagerli, UM., Gadeberg, O., Østenstad, B., Sundström, C., Delabie, J., Ralfkier, E., Vornanen, M.
& D'Amore, F. A. (2011).
Intensive induction chemotherapy followed by autologous stem cell transplantation (ASCT) in patients with enteropathy-associated T-cell lymphoma: a prospective study by the Nordic Lymphoma Group (NLG-T-01).
Blood,
116(21), 3565.
Toft-Petersen, M.
, Kamper, P., Albertsen, S., Secher, L., Segel, EK., Clausen, M.
& D'Amore, F. A. (2011).
Monocytosis in the peripheral blood at first relapse/progression predicts poorer overall and progression-free survival after autologous hematopoietic stem cell transplantation in Hodgkin lymphoma. Blood,
118, 1559.
Strandhave, C., Jespersen, B., Jørgensen, KA., Schou, R.
, Søndergaard, E., Bendix, K., Mortensen, LS.
& D'Amore, F. A. (2011).
Posttransplant lymphoproliferative disorders (PTLD) after renal transplantation: Focus on HLA Antigens.
Blood,
116(21), 5074.
Hohloch, K., Lorsbach, M., Windemuth-Kieselbach, C., Gomez-Codina, J., Likesch, W., Jurczak, W., Cacchione, R., Suh, C., Johnsen, AR.
, D'Amore, F. A., Decaudin, D., Zinzani, PL. & Trümper, L. (2011).
Radioimmunotherapy confers long-term survival to lymphoma patients with acceptable toxicity: Registry analysis of 1100 patients by the international Radioimmunotherapy network (RIT-N).
Journal of Nuclear Medicine,
52(9), 1354-1360.
El-Galaly, T. C., D'Amore, F. A., Brown, P. D. N.
, Christiansen, I., Spect, L., Loft, A.
, Bukh, A., Johnsen, HE., Madsen, C. & Hutchings, M. (2011).
Routine bone marrow biopsy adds little diagnostic information in patients with newly diagnosed Hodgkin lymphoma undergoing PET/CT staging. Blood,
118, 2627.
El-Galaly, T. C. E., D'Amore, F. A., Brown, P. D. N.
, Christiansen, I., Specht, L., Loft, A.
, Bukh, A., Johnsen, H. E., Madsen, C. & Hutchings, M. (2011).
Routine Bone Marrow Biopsy Adds Little Diagnostic Information in Patients with Newly Diagnosed Hodgkin Lymphoma Undergoing PET/CT Staging. Poster session presented at ASH, San Diego, United States.
Agostinelli, C., Gallamini, A., Rigacci, L., Vitolo, U., Stracqualursi, L., Piccaluga, P., Stelitano, C., Patti, C., Argani, L., Broccoli, A., Levis, A.
, D'Amore, F. A., Zinzani, P. & Pileri, SA. (2011).
The prognostic value of biologic markers in classical Hodgkin Lymphoma (CHL) patients.
Annals of Oncology,
22(4), 206.
Ludvigsen, M., Kamper, P., Bendix, K., Hamilton Dutoit, S. J., Rabinovich, G. A., Møller, M. B.
, Nyengaard, J. R., D'Amore, F. A. & Honoré, B. (2011).
Translational research identifies prognostic markers including galectin-1 in the tumor microenvironment of cHL predictive for relapsed /refractory disease.
Kamper, P., Bendix, K., Hamilton-Dutoit, S., Honoré, B., Nyengaard, J. R. & d'Amore, F. (2011).
Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma.
Haematologica,
96(2), 269-76.
https://doi.org/10.3324/haematol.2010.031542
Relander, T., Lauritzsen, G. F., Jantunen, E., Hagberg, H., Anderson, H., Cavallin-Ståhl, E., Holte, H., Østerborg, A., Merup, M., Brown, P. D. N., Østenstad, B., Kuittinen, O., Erlanson, M., Fagerli, UM., Gadeberg, O., Sundström, C., Delabie, J., Ralfkier, E., Vornanen, M.
& D'Amore, F. A. (2010).
favorable outcome in ALK-negative anaplastic large-cell lymphoma following intensive induction chemotherapy and autologous stem cell transplantation (ASCT): a prospective study by the Nordic Lymphoma Group (NLG-T-01).
Blood,
116(21).
Kelsen, J., Schwindt, H., Dige, A. K., D'Amore, F. A., Pedersen, F. S., Agnholt, J., Christensen, L. A., Dahlerup, J. F. & Hvas, C. L. (2010).
Infliximab drives gamma-delta T cell expansion in Crohn's disease - a predictor of lymphoma risk? Blood,
116(21), 4131.
d'Amore, F., Radford, J., Relander, T., Jerkeman, M., Tilly, H., Osterborg, A., Morschhauser, F., Gramatzki, M., Dreyling, M., Bang, B. & Hagberg, H. (2010).
Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma.
British Journal of Haematology, Supplement,
150(5), 565-73.
https://doi.org/10.1111/j.1365-2141.2010.08298.x
D'Amore, F. A., Madsen, J., Nielsen, R., Engebjerg, M., Sørensen, H. & Bukh, A. (2010).
Use of statins and prognosis in patients with CD-20-positive "De novo" diffuse large b cell lymphoma (DLBCL) treated with rituximab containing regimens.
Haematologica, 282.
Jepsen, J. R.
, d'Amore, F., Baandrup, U.
, Clausen, M. R., Gottschalck, E. & Aasted, B. (2009).
Aleutian mink disease virus and humans.
Emerging Infectious Diseases (Print Edition),
15(12), 2040-2.
https://doi.org/10.3201/eid1512.090514D'Amore, F. A., Jurczak, W., Skotnicki, A. B., Deptala, A., Windemuth-Kieselbach, C., Lorsbach, M., Delaloye, A. B., Cheolwon, S., Zinzani, P. L., Cacchione, R., Linkesch, W. & Truemper, L. H. (2009).
Consolidation with radioimmunotherapy may prolong survival in first remission of mantle cell lymphoma patients uneligible for stem cell transplantation, an analysis of the international RIT-network.
Blood,
114(22), 22.
Jørgensen, J. M., Sørensen, F. B., Bendix, K., Nielsen, J. L., Funder, A., Karkkainen, M. J., Tainola, T.
, Sørensen, A. B., Pedersen, F. S. & D'Amore, F. (2009).
Expression level, tissue distribution pattern, and prognostic impact of vascular endothelial growth factors VEGF and VEGF-C and their receptors Flt-1, KDR, and Flt-4 in different subtypes of non-Hodgkin lymphomas.
Leukemia and Lymphoma,
50(10), 1647-1660.
https://doi.org/10.1080/10428190903156729,
https://doi.org/10.1080/10428190903156729
Ludvigsen, M., Ostergaard, M.
, Vorum, H., Jacobsen, C. & Honoré, B. (2009).
Identification and characterization of endonuclein binding proteins: evidence of modulatory effects on signal transduction and chaperone activity.
B M C Biochemistry,
10(1), 34.
https://doi.org/10.1186/1471-2091-10-34
Zinzani, P. L.
, d'Amore, F., Bombardieri, E., Brammer, C., Codina, J. G., Illidge, T., Jurczak, W., Linkesch, W., Morschhauser, F., Vandenberghe, E. & Van Hoof, A. (2008).
Consensus conference: implementing treatment recommendations on yttrium-90 immunotherapy in clinical practice - report of a European workshop.
European Journal of Cancer,
44(3), 366-73.
https://doi.org/10.1016/j.ejca.2007.12.008Jørgensen, J. M., Sørensen, F. B., Bendix, K., Nielsen, J. L., Funder, A. M. D., Karkkainen, M. J., Tainola, T.
, Pedersen, F. S., Sørensen, A. B., Kühle, A. V. D. A. & d'Amore, F. A. (2008).
Correlation between epstein-barr virus (EBV) RNA expression and vascular endothelial growth factor (VEGF) expression in different subtypes of peripheral T-cell lymphomas (PTCL) and prognostic implications. In
ANNALS OF ONCOLOGY (Vol. 19, pp. 113-113)
Morschhauser, F., Radford, J., Van Hoof, A., Vitolo, U., Soubeyran, P., Tilly, H., Huijgens, P. C., Kolstad, A.
, d'Amore, F., Gonzalez Diaz, M., Petrini, M., Sebban, C., Zinzani, P. L., van Oers, M. H. J., van Putten, W., Bischof-Delaloye, A., Rohatiner, A., Salles, G., Kuhlmann, J. & Hagenbeek, A. (2008).
Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma.
Journal of Clinical Oncology,
26(32), 5156-64.
https://doi.org/10.1200/JCO.2008.17.2015Dybkær, K., Iqbal, J., Zhou, G., Geng, H., Xiao, L.
, Schmitz, A., d'Amore, F. A. & Chan, W. C. (2007).
Genome wide transcriptional analysis of resting and IL2 activated human natural killer cells: Gene expression signatures indicative of novel molecular signaling pathways. BMC Gemomics.
BMC Gemomics,
8(230).
Hutchings, M., Loft, A., Hansen, M., Pedersen, L. M., Berthelsen, A. K.
, Keiding, S., d'Amore, F. A., Boesen, A. M., Mikkelsen, L. R. & Specht, L. (2006).
Positron emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma.
Haematologica,
91, 482-9.
Kamper, P., Kjeldsen, E., Clausen, N., Bendix, K., Hamilton-Dutoit, S. & d'Amore, F. (2005).
Epstein-Barr virus-associated familial Hodgkin lymphoma: paediatric onset in three of five siblings.
British Journal of Haematology,
129(5), 615-7.
https://doi.org/10.1111/j.1365-2141.2005.05499.x
de Chadarevian, JP., Wolk, JH., Inniss, S., Lischner, HW.
, d'Amore, F. A., Faerber, EN. & Isaacson, GC. (1997).
A newly recognized cause of wheezing:AIDS-related bronchial leiomyomas. Pediatric Pulmonology,
24((2)), 106-10.
Smir, BN., Hauke, RJ., Bierman, PJ., Gross, TG.
, d'Amore, F. A., Anderson, JR. & Greiner, TC. (1997).
Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in posttransplant lymphoproliferative disorders.
Laboratory Investigation,
76((3)), 439.
d'Amore, F. A., Stribley, JA., Ohno, T., Wu, G., Wickert, RS., Delabie, J., Hinrichs, SH. & Chan, W. C. (1997).
Molecular studies on single cells harvested by micromanipulation from archival tissue sections previously stained by immunohistochemistry or nonisotopic in situ hybridization.
Laboratory Investigation,
76((2)), 219-24.
d'Amore, F. A., Johansen, P., Houmand, A., Weisenburger, DD. & Mortensen, L. (1996).
Epstein-Barr virus genome in non-Hodgkin's lymphomas occuring in immunocompetent patients: highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis. Danish Lymphoma Study Group, LYFO. Blood,
87((3)), 1045-55.
Smir, BN., Hauke, RJ., Bierman, PJ., Gross, TG.
, d'Amore, F. A., Anderson, JR. & Greiner, TG. (1996).
Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in posttransplant lymphoproliferative disorders. Laboratory Investigation,
75((4)), 575-88.